Sirio Pharma

Sirio Pharma Co., Ltd. (SIRIO), founded in 1993, was listed on the Shenzhen Stock Exchange in 2019 (stock code: 300791.SZ). After over 30 years of rapid growth, SIRIO has emerged as a globally recognized leading nutrition product solution provider, encompassing market insights, customized solutions, differentiated R&D, global production capabilities, industry-wide collaboration and marketing empowerment. SIRIO is committed to serving clients and consumers worldwide, operating Seven automated production bases and five R&D centers across the globe. Through strategic partnerships with leading domestic and international enterprises, the company has positioned itself as one of the most influential players in the industry.